## Candidate Studies

"GSE114002" "GSE139516" "GSE147194" "GSE147507" "GSE148729" "GSE47792"

## Studies that fit the criteria

GSE139516: expression of cirRNA, miRNA and mRNA were examined in samples of MERS-CoV infected (6hpi and 24hpi) and mock infected human lung adenocarcinoma (Calu-3) cells. 

## Studies that don't fit the criteria

GSE114002: Isn't about MERS

GSE147194: Isn't about MERS (but about SARS-CoV-2)

GSE147507: Isn't about MERS (but about SARS-CoV-2)

GSE148729: Isn't about MERS (but about SARS-CoV-2)

GSE47792: not about MERS

## Contrasts

SRP227272: Calu-3 cells mock infection versus MERS-CoV 6 hours post infection (mRNA): mock;SRX7066767,SRX7066768,SRX7066769: 6 hours post infection;SRX7066770,SRX7066771,SRX7066772;

SRP227272: Calu-3 cells mock infection versus MERS-CoV 24 hours post infection (mRNA): mock;SRX7066767,SRX7066768,SRX7066769: 24 hours post infection;SRX7066773,SRX7066774,SRX7066775;

SRP227272: Calu-3 cells mock infection versus MERS-CoV 6 hours post infection (miRNA): mock;SRX7066776,SRX7066777,SRX7066778: 6 hours post infection;SRX7066779,SRX7066780,SRX7066781;

SRP227272: Calu-3 cells mock infection versus MERS-CoV 24 hours post infection (miRNA): mock;SRX7066776,SRX7066777,SRX7066778: 24 hours post infection;SRX7066782,SRX7066783,SRX7066784;

SRP227272: Calu-3 cells mock infection versus MERS-CoV 6 hours post infection (cirRNA): mock;SRX7066785,SRX7066786,SRX7066787: 6 hours post infection;SRX7066788,SRX7066789,SRX7066790;

SRP227272: Calu-3 cells mock infection versus MERS-CoV 24 hours post infection (cirRNA):mock;SRX7066785,SRX7066786,SRX7066787: 24 hours post infection;SRX7066791,SRX7066792,SRX7066793;

